Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.).
Palmerini E, Reichardt P, Hall KS, Bertulli R, Bielack SS, Comandone A, Egerer G, Hansmeier A, Kevric M, Carretta E, Hansson L, Jebsen N, Eriksson M, Bruland ØS, Donati DM, Ibrahim T, Smeland S, Ferrari S.
Palmerini E, et al.
Cancer. 2023 Nov 15;129(22):3564-3573. doi: 10.1002/cncr.34964. Epub 2023 Aug 2.
Cancer. 2023.
PMID: 37530385